Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FQX22
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,386
Award facts
- Contract value 100% obligated
- $7,386.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, valued at $7,386.40 for the supply of RINVOQ ER 15 mg tablets (30-count units). This is a firm fixed price delivery order with an ultimate completion date of June 2, 2025, and represents a non-competitive set-aside award. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that supports global pharmaceutical supply to military healthcare systems.
AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, serves as a critical supplier for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other military healthcare systems. The company's extensive contract portfolio with the DLA demonstrates its capability to deliver a comprehensive range of pharmaceutical products, from specialty medications and brand-name drugs to vaccines and medical supplies across multiple therapeutic domains. This particular delivery order for RINVOQ ER tablets, used in the treatment of rheumatoid arthritis and other inflammatory conditions, exemplifies the company's role in supplying specialized pharmaceutical commodities to support military personnel and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FQX22?
SPE2DB25FQX22 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FQX22 worth?
The government has obligated $7,386 on SPE2DB25FQX22.
Is contract SPE2DB25FQX22 an order under another contract?
Yes. SPE2DB25FQX22 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQX22 competed?
The extent of competition for SPE2DB25FQX22 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award